MIP Diagnostics Spotted at SLAS2019
9 TOP TECHNOLOGIES FROM THE EXHIBITION FLOOR
SelectScience editors reflect on the most exciting technologies showcased at the 2019 Society for Laboratory Automation and Screening conference and we are mentioned for our new Epitope Mapping Service.
MIPs in Space!
MIPs go Stratospheric!
A visit to the stratosphere demonstrates the exceptional robustness of MIPs which retain their function on return to earth. This was debuted at our Seminar in September 2018.
Paper published in ChemNanoMat
A Novel Assay Format as an Alternative to ELISA: MINA Test for Biotin – Is a published paper in ChemNanoMat with contributions made by Joanna Czulak of MIP Diagnostics, alongside colleagues at The University of Leicester and Imperial College London.
Paper published in the Journal of Advanced Materials Society
Novel assay format for proteins based on magnetic molecularly imprinted polymer nanoparticles—detection of pepsin is a published paper in the Journal of Chinese Advanced Materials Society, with contributions made by Joanna Czulak, Antonio Guerreiro and Francesco Canfarotta from MIP Diagnostics, alongside colleagues at The University of Leicester.
MIP Diagnostics Seminar
Join us for a day of presentations, networking, and discussions with key opinion leaders in the field of imprinted polymers and sensors.
OBN Awards Nomination
MIP Diagnostics are proud to be shortlisted as finalists at the OBN Awards in October.
Andy Lakey Joins as Senior Scientist
Dr Andrew Lakey brings his experience of developing point of care immunodiagnostics platforms to MIP Diagnostics, as a Senior Scientist.
New MIP Diagnostics Marketing Material
MIP Diagnostics have produced a new flyer featuring MIP technology and applications.
New Director of Diagnostics Development
MIP Diagnostics Ltd is pleased to announce that Alan Thomson has joined the company to lead the diagnostics development work.
Move to Colworth Park
MIP Diagnostics Ltd has moved from the founding laboratory at the University of Leicester, to new labs and offices at Colworth Park in Sharnbrook, Bedfordshire.
MIP New Investment
A Midlands-based life sciences company which develops ‘plastic antibodies’ has closed a £1.5m Series A funding round supported by Mercia Fund Managers and a number of private investors.
Jim Reid Appointed Chairman
To further support its plans for expansion, MIP Diagnostics has appointed Jim Reid as chair to provide valuable commercial expertise.